Hepion Pharmaceuticals Rings the Closing Bell

About This Event

Hepion Pharmaceuticals (Nasdaq: HEPA), a biotechnology company headquartered in Edison, New Jersey developing a drug to combat fibrosis and NASH, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Dr. Robert Foster, CEO, rings the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore